The Patent Finder

Grifols, S.A.

49 patents currently held · Updated Nov 15, 2026
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
10
Ending by 2030
Feb 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Jan 2 to 16, 2027 · next Jan 2
  • 2 fees due May 24 to 28, 2027 · next May 24
  • 2 fees due Jun 1 to 8, 2027 · next Jun 1
  • 2 fees due Aug 16 to 20, 2027 · next Aug 16
  • 1 fee due Sep 15, 2027
    The maintenance fee for Priming Anticoagulant Alignment for Blood Extraction (US 9,283,316) comes due Sep 15, 2027. Unpaid by Mar 15, 2028, it lapses early.
  • 3 fees due Oct 21, 2027

Which patents, and when each one lapses · Pro

Recent changes

  • 3 of the patents on this record were granted since Aug 17, 2026
  • 1 term has ended since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 7,531,513Therapeutic Preparation of Very High Purity Fviia and Method for Obtaining Same
In force
 · High confidence
In forceHigh confidence
US 8,084,580Therapeutic Human Albumin Solutions with Low Prekallikrein Activator (PKA) Activity and Process for Obtaining Them
In force
 · High confidence
In forceHigh confidence
US 7,622,078Apparatus for the Automated Clinical Analysis of Samples
In force
 · High confidence
In forceHigh confidence
US 7,851,446Use of Therapeutic Human Albumin for Treatment of Alzheimer's Disease
In force
 · High confidence
In forceHigh confidence
US 8,231,599Process for Obtaining High Efficiency Human Albumin for Use in Detoxification Therapy
In force
 · High confidence
In forceHigh confidence
US 8,454,909Device for Loading Reagent Cards for Clinical Analysers
In force
 · High confidence
In forceHigh confidence
US 7,931,916Composition of Biocompatible Microparticles of Alginic Acid for the Controlled Release of Active Ingredients by Intravenous Administration
In force
 · High confidence
In forceHigh confidence
US 8,088,416Process for Obtaining High Efficiency Human Albumin for Use in Detoxification Therapy
In force
 · High confidence
In forceHigh confidence
US 8,354,505Process for Obtaining a Concentrate of Von Willebrand Factor or a Complex of Factor VIII/Von Willebrand Factor and Use of the Same
In force
 · High confidence
In forceHigh confidence
US 8,252,590Mammalian Cell Culture Media Which Comprise Supernatant from Cohn Fractionation Stages and Use Thereof
In force
 · High confidence
In forceHigh confidence
10 of 49 patents shown.
Pro members see all 49.
Pro members: see all 49 patents
Also on record, not counted in the 49: 1 patent in force now held by others · 19 lapsed for an unpaid fee · 22 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 10 abandoned · 5 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited